VBI Vaccines Retained Earnings vs. Market Capitalization

VBIV Stock  USD 0.63  0.02  3.28%   
Based on VBI Vaccines' profitability indicators, VBI Vaccines may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in May. Profitability indicators assess VBI Vaccines' ability to earn profits and add value for shareholders.
 
Retained Earnings  
First Reported
1997-12-31
Previous Quarter
-582.4 M
Current Value
-582.4 M
Quarterly Volatility
150 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 1,001 in 2024. Days Sales Outstanding is likely to drop to 34.64 in 2024. At this time, VBI Vaccines' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Income Tax Expense is likely to climb to about 33.4 M in 2024, despite the fact that Income Before Tax is likely to grow to (88.2 M).
For VBI Vaccines profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VBI Vaccines to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VBI Vaccines utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VBI Vaccines's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VBI Vaccines over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.79)
Revenue Per Share
0.689
Quarterly Revenue Growth
19.896
Return On Assets
(0.29)
Return On Equity
(2.20)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VBI Vaccines Market Capitalization vs. Retained Earnings Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining VBI Vaccines's current stock value. Our valuation model uses many indicators to compare VBI Vaccines value to that of its competitors to determine the firm's financial worth.
VBI Vaccines is rated below average in retained earnings category among related companies. It is rated below average in market capitalization category among related companies . VBI Vaccines reported Retained Earnings of (582.45 Million) in 2023. Comparative valuation analysis is a catch-all model that can be used if you cannot value VBI Vaccines by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VBI Vaccines' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VBI Vaccines' earnings, one of the primary drivers of an investment's value.

VBI Market Capitalization vs. Retained Earnings

Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

VBI Vaccines

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

 = 
(582.45 M)
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

VBI Vaccines

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
17.06 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

VBI Market Capitalization vs Competition

VBI Vaccines is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 18.51 Billion. VBI Vaccines adds roughly 17.06 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Total debt  Workforce  Valuation  Revenue

VBI Vaccines Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in VBI Vaccines, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VBI Vaccines will eventually generate negative long term returns. The profitability progress is the general direction of VBI Vaccines' change in net profit over the period of time. It can combine multiple indicators of VBI Vaccines, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income28.3 M29.7 M
Operating Income-79.9 M-75.9 M
Income Before Tax-92.8 M-88.2 M
Total Other Income Expense Net-12.9 M-12.3 M
Net Loss-92.8 M-88.2 M
Income Tax Expense31.8 M33.4 M
Net Loss-114 M-108.3 M
Net Loss-102 M-96.9 M
Interest IncomeM2.1 M
Net Interest Income-5.9 M-5.6 M
Non Operating Income Net Other-24.7 M-23.5 M
Change To Netincome44.3 M46.5 M
Net Loss(0.01)(0.01)
Income Quality 0.66  0.99 
Net Income Per E B T 1.43  1.44 

VBI Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on VBI Vaccines. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VBI Vaccines position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VBI Vaccines' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in VBI Vaccines without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
All  Next Launch Module

Use Investing Themes to Complement your VBI Vaccines position

In addition to having VBI Vaccines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Music and Video Thematic Idea Now

Music and Video
Music and Video Theme
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
View All  Next Launch
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out World Market Map.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
To fully project VBI Vaccines' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of VBI Vaccines at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include VBI Vaccines' income statement, its balance sheet, and the statement of cash flows.
Potential VBI Vaccines investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although VBI Vaccines investors may work on each financial statement separately, they are all related. The changes in VBI Vaccines's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VBI Vaccines's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.